Skip to content

In a drive to reduce high cervical-cancer rates in Nigeria, a nonprofit organization co-founded by Stanford oncology researcher Ami Bhatt, MD, PhD, has enlisted the imaginative assistance of an educational comic book.

In a drive to reduce high cervical-cancer rates in Nigeria, a nonprofit organization co-founded by Stanford oncology researcher Ami Bhatt, MD, PhD, has enlisted the imaginative assistance of an educational comic book.

Published on

A novel immunotherapy appears safe for use in patients with non-Hodgkin’s lymphoma. Here, a Northern California man shares his experience in the study.

A novel immunotherapy appears safe for use in patients with non-Hodgkin’s lymphoma. Here, a Northern California man shares his experience in the study.

A Stanford-designed computer algorithm helps doctors predict the lifespan of patients with metastatic cancer by looking for clues in their own exam notes.

A Stanford-designed computer algorithm helps doctors predict the lifespan of patients with metastatic cancer by looking for clues in their own exam notes.

Published on

In a new study, a team of researchers has examined the relationship between protein binding to DNA and the development of cancer.

In a new study, a team of researchers has examined the relationship between protein binding to DNA and the development of cancer.

Cancerous tumors cause disease in two ways: they grow and spread. But a new immune therapy approach may be able to target both problems simultaneously.

Cancerous tumors cause disease in two ways: they grow and spread. But a new immune therapy approach may be able to target both problems simultaneously.

Published on

Hiding mRNA messages in CARTs — positively charged degradable vehicles —smuggles them across the cell membrane and can 'vaccinate' against cancer in mice.

Hiding mRNA messages in CARTs — positively charged degradable vehicles —smuggles them across the cell membrane and can 'vaccinate' against cancer in mice.

Published on

Mapping the geography of the immune response in triple negative breast cancers predicts patient survival and sheds light onto new aspects of tumor biology.

Mapping the geography of the immune response in triple negative breast cancers predicts patient survival and sheds light onto new aspects of tumor biology.

Published on

The true driver mutations of cancer are almost always common to all metastases in an individual, according to a Stanford scientist and other researchers.

The true driver mutations of cancer are almost always common to all metastases in an individual, according to a Stanford scientist and other researchers.

Published on